InvestorsObserver
×
News Home

Can Phathom Pharmaceuticals Inc (PHAT) Stock Rise to the Top of Healthcare Sector Friday?

Friday, August 18, 2023 12:15 PM | InvestorsObserver Analysts

Mentioned in this article

Can Phathom Pharmaceuticals Inc (PHAT) Stock Rise to the Top of Healthcare Sector Friday?

Phathom Pharmaceuticals Inc (PHAT) is around the top of the Healthcare sector according to InvestorsObserver. PHAT received an overall rating of 52, which means that it scores higher than 52% of stocks. Additionally, Phathom Pharmaceuticals Inc scored a 92 in the Healthcare sector, ranking it higher than 92% of stocks in that sector.

Overall Score - 52
PHAT has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on PHAT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 52 means the stock is more attractive than 52 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Phathom Pharmaceuticals Inc Stock Today?

Phathom Pharmaceuticals Inc (PHAT) stock is trading at $15.05 as of 12:14 PM on Friday, Aug 18, a gain of $0.51, or 3.51% from the previous closing price of $14.54. The stock has traded between $14.27 and $15.08 so far today. Volume today is low. So far 38,750 shares have traded compared to average volume of 291,096 shares. Click Here to get the full Stock Report for Phathom Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App